Live Webinar: "TCR Discovery and Validation" Register Now.

Challenge the Limits of Immune Monitoring

Explore how Dextramer® technology can advance a diverse range of applications – from the development of cell therapies and vaccines, to TCR and antibody discovery. Learn how innovative TCR Dextramer® technology can help you to understand the efficacy of cancer immunotherapies or control the quality of cancer vaccines.

Focus on Insights

Cell Therapy

The key to developing the next generation of cell therapies includes understanding the interaction between T cells and antigen-presenting cells. Explore how Dextramer® technology can aid in target discovery in addition to detection, isolation, and validation of antigen-specific cells in cell therapy development and GMP manufacturing.

Vaccine Development

Explore how Dextramer® reagents can help you monitor antigen-specific immune cells.

Object reference not set to an instance of an object.

COVID-19

A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at risk, and even prepare for the next pandemic.

Antibody Discovery

Identification of B-cell specificities for antibody discovery used to be a lengthy and costly process. Find out how using dCODE® Klickmer can replace other methods in an overall workflow to identify possible BCR specificities and their applications in antibody discovery.

Reliable Detection of Peptide-MHC Complexes with TCR Dextramer®

Get your soluble T-cell receptor (TCR) or your TCR Dextramer® molecule with the benefits and quality of the Dextramer® technology, displaying your chosen TCR on it. Provide us with your TCR sequences or find it out in your lab using dCODE Dextramer® single-cell multi-omics, and we will build it for you. Find out more by contacting us at [email protected]